2
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Effects of androgens on aromatase activity and 11 C-vorozole binding in granulosa cells in vitro

, , , , , , , & show all
Pages 209-215 | Published online: 07 Aug 2009

References

  • Inkster SE, Brodie AM. Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J Clin Endocrinol Metab 1991; 73: 717–26.
  • Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the ‘two-cell, two-gonadotrophin’ model revisited. Mol Cell Endocrinol 1994; 100: 51–4.
  • Suzuki T, Sasano H, Tamura M, Aoki H, Fukaya T, Yajima A et al. Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries: in situ hybridization and immunohistochemical study. Mol Cell Endocrinol 1993; 97: 135–43.
  • Robertson DM, Burger HG. Reproductive hormones: ageing and the perimenopause. Acta Obstet Gynecol Scand 2002; 81: 612–6.
  • McNatty KP. Hormonal correlates of follicular development in the human ovary. Aust J Biol Sci 1981; 34: 249–68.
  • Fitzpatrick SL, Richards JS. Regulation of cytochrome P450 aromatase messenger ribonucleic acid and activity by steroids and gonadotropins in rat granulosa cells. Endocrinology 1991; 129: 1452–62.
  • Zimniski SJ, Brandt ME, Covey DF, Puett D. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative. Steroids 1987; 50: 135–46.
  • Steinkampf MP, Mendelson CR, Simpson ER. Regulation by follicle-stimulating hormone of the synthesis of aromatase cytochrome P-450 in human granulosa cells. Mol Endocrinol 1987; 1: 465–71.
  • Chan WK, Tan CH. Induction of aromatase activity in porcine granulosa cells by FSH and cyclic AMP. Endocr Res 1987; 13: 285–99.
  • Whitelaw PF, Smyth CD, Howles CM, Hillier SG. Cell-specific expression of aromatase and LH receptor mRNAs in rat ovary. J Mol Endocrinol 1992; 9: 309–12.
  • Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod 1998; 4: 1–8.
  • Lephart ED, Simpson ER, McPhaul MJ. Ovarian aromatase cytochrome P-450 mRNA levels correlate withenzyme activity and serum estradiol levels in anestrous, pregnant and lactating rats. Mol Cell Endocrinol 1992; 85: 205–14.
  • Suzuki K, Tamaoki BI. Postovulatory decrease in estrogen production is caused by the diminished supply of aromatizable androgen to ovarian aromatase. Endocrinology 1980; 107: 2115–6.
  • Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84: 2951–6.
  • Hillier SG. Intrafollicular paracrine function of ovarian androgen. J Steroid Biochem 1987; 27: 351–7.
  • Hillier SG, de Zwart FA. Androgen/antiandrogen modulation of cyclic AMP-induced steroidogenesis during granulosa cell differentiation in tissue culture. Mol Cell Endocrinol 1982; 28: 347–61.
  • Hillier SG, Tetsuka M. Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol 1997; 11: 249–60.
  • Wada Y, Tsuiki A, Fukaya T, Shinkawa O, Satoh S, Horiguchi M et al. Effects of androgen on 17 betaestradiol production by cultured human granulosa cells. Tohoku J Exp Med 1988; 154: 253–60.
  • Harlow CR, Hillier SG, Hodges JK. Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary. Endocrinology 1986; 119: 1403–5.
  • Hillier SG, van den Boogaard AM, Reichert LE Jr, van Hall EV. Alterations in granulosa cell aromatase activity accompanying preovulatory follicular development in the rat ovary with evidence that 5alpha-reduced C19 steroids inhibit the aromatase reaction in vitro. J Endocrinol 1980; 84: 409–19.
  • Meijs-Roelofs HM, Kramer P, van Cappellen WA, Gri-bling-Hegge L, Woutersen PJ. Periovulatory changes in serum concentration and ovarian content of 5 alpha-androstane-3 alpha, 17 beta-diol in the adult rat. Biol Reprod 1986; 35: 890–6.
  • Brandt ME, Puett D, Zimniski SJ. Divergence between ovarian aromatase activity, estrogen, and androgen levels in the cycling rat. Endocrinology 1990; 126: 72–9.
  • Dupon C, Kim MH. Peripheral plasma levels of testosterone, androstenedione, and oestradiol during the rat oestrous cycle. J Endocrinol 1973; 59: 653–4.
  • Kellis JT Jr, Vickery LE. The active site of aromatase cytochrome P-450. Differential effects of cyanide provide evidence for proximity of heme-iron and carbon-19 in the enzyme-substrate complex. J Biol Chem 1987; 262: 8840–4.
  • Kirilovas D, Bergstrom M, Bonasera TA, Bergstrom-Pettermann E, Naessen T, Holte J et al. In vitro evaluation of aromatase enzyme in granulosa cells using a [11C]vorozole binding assay. Steroids 1999; 64: 266–72.
  • Newton CJ, Samuel DL, James VH. Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal adipose tissue. J Steroid Biochem 1986; 24: 1033–9.
  • Lidstrom P, Bonasera TA, Kirilovas D, Lindblom B, Lu L, Bergstrom E et al. Synthesis, in vivo rhesus monkey biodistribution and in vitro evaluation of a 11C-labelled potent aromatase inhibitor: [N-Methyl-11C]vorozole. Nucleic Med Biol 1998; 25: 497–501.
  • Johnston RF, Pickett SC, Barker DL. Autoradiography using storage phosphor technology. Electrophoresis 1990; 11: 355–60.
  • Koymans LM, Moereels H, Vanden Bossche H. A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase). J Steroid Biochem Mol Biol 1995; 53: 191–7.
  • Chabab A, Sultan C, Fenart O, Descomps B. Stimulation of aromatase activity by dihydrotestosterone in human skin fibroblasts. J Steroid Biochem 1986; 25: 165–9.
  • Hillier SG, De Zwart FA. Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in-vitro. Endocrinology 1981; 109: 1303–5.
  • Daniel SA, Armstrong DT. Involvement of estrogens in the regulation of granulosa cell aromatase activity. Can J Physiol Pharmacol 1983; 61: 507–11.
  • Zhuang LZ, Adashi EY, Hsuch AJ. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology 1982; 110: 2219–21.
  • Brailly S, Gougeon A, Milgrom E, Bomsel-Helmreich O, Papiernik E. Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. J Clin Endocrinol Metab 1981; 53: 128–34.
  • Agarwal SK, Judd HL, Magoffin DA. A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 3686–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.